Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹602.7
  • Day's High
  • ₹619.6
₹ 616.95
  • 52-w low
  • ₹262.39
  • 52-w high
  • ₹639.7
616.95
  • Day's open
    ₹609
  • Previous close
    ₹606.099976
  • VWAP
    ₹613.89
  • Lower price band
    ₹586.1
  • Upper price band
    ₹647.75

Today's Market Action

The last traded share price of Solara Active Pharma Sciences Ltd was 616.95 up by 1.79% on the NSE. Its last traded stock price on BSE was 613.10 up by 1.34%. The total volume of shares on NSE and BSE combined was 53,198 shares. Its total combined turnover was Rs 3.27 crores.

Medium and Long Term Market Action

Solara Active Pharma Sciences Ltd hit a 52-week high of 639.7 on 11-07-2024 and a 52-week low of 262.39 on 01-11-2023. The stock price of Solara Active Pharma Sciences Ltd is down by 0% over the last one month. It is up by 59.52% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 2221

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Solara Active Pharma Sciences Ltd?

What is the Market Cap of Solara Active Pharma Sciences Ltd?

What is PE Ratio of Solara Active Pharma Sciences Ltd?

What is PB Ratio of Solara Active Pharma Sciences Ltd?

What is the CAGR of Solara Active Pharma Sciences Ltd?

How to Buy Solara Active Pharma Sciences Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Above Average Growth Rate
    The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only -38.93% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Negative operating earnings and interest coverage
    The company has a negative operating earnings and a negative Interest coverage ratio of -0.90 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.92. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 184 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 38% of the total company's shareholding which can have a significantly negative impact on stock.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(27/07/2024)
Stock Valuation
Yellow line
89
87.50%
87.50% People are bullish about Solara Active Pharma Sciences Ltd
12.50%
12.50 % People are bearish about Solara Active Pharma Sciences Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Solara Active Pharma Sciences Ltd

616.95 +10.85 (1.79%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %